Zobrazeno 1 - 10 of 102 pro vyhledávání: '"Berven FS"'
1
A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking
Autor: Teunissen, CE, Petzold, A, Bennett, JL, Berven, FS, Brundin, L, Comabella, M, Franciotta, D, Federiksen, JL, Fleming, JO, Furlan, R, Hintzen, Rogier, Hughes, SG, Johnson, MH, Krasulova, E, Kuhle, J, Magnone, MC, Rajda, C, Rejdak, K, Schmidt, HK, van Pesch, V, Waubant, E, Wolf, C, Giovannoni, G, Deisenhammer, F, Hegen, H, Hemmer, B, Tumani, HT
Publikováno v: Teunissen, C E, Petzold, A F S, Bennett, J L, Berven, F S, Brundin, L, Comabella, M, Franciotta, D, Federiksen, J L, Fleming, J O, Furlan, R, Hintzen, R Q, Hughes, S G, Johnson, M H, Krasulova, E, Kuhle, J, Magnone, M C, Rajda, C, Rejdak, K, Schmidt, H K, van Pesch, V, Waubant, E, Wolf, C, Giovannoni, G, Deisenhammer, F, Hegen, H, Hemmer, B & Tumani, H T 2010, ' A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking ', Laboratoriumsmedizin, vol. 34, no. 1, pp. 1-12 . https://doi.org/10.1515/JLM.2010.001
Laboratoriumsmedizin, 34(1), 1-12
Laboratoriumsmedizin-Journal of laboratory medicine, 34(1), 1-12. De Gruyter
There is a long history of research on body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only very few biomarkers in cerebrospinal fluid (CSF) are being used in clinical practice. One of the most critical factors in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::145d5b38c1aed7eee96c27df399196f4
https://research.vumc.nl/en/publications/b667421c-5143-417f-b86d-2d6c78d88f9f
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
Autor: Lereim RR; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway., Nytrova P; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Guldbrandsen A; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway., Havrdova EK; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Myhr KM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Barsnes H; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway., Berven FS; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.
Publikováno v: PloS one [PLoS One] 2024 Mar 25; Vol. 19 (3), pp. e0300914. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Autor: Tijms BM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands. b.tijms@amsterdamumc.nl.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands. b.tijms@amsterdamumc.nl., Vromen EM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., Mjaavatten O; Proteomics Unit at the University of Bergen, Department of Biomedicine, University of Bergen, Bergen, Norway., Holstege H; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Department of Clinical Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands., Reus LM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., van der Lee S; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands., Wesenhagen KEJ; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., Lorenzini L; Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neuroimaging, Amsterdam, the Netherlands., Vermunt L; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Neurochemistry Laboratory, Department of Laboratory Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands., Venkatraghavan V; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., Tesi N; Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Delft Bioinformatics Lab, Delft University of Technology, Delft, the Netherlands., Tomassen J; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., den Braber A; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Goossens J; ADx NeuroSciences, Ghent, Belgium., Vanmechelen E; ADx NeuroSciences, Ghent, Belgium., Barkhof F; Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK., Pijnenburg YAL; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands., van der Flier WM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Epidemiology & Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands., Teunissen CE; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Neurochemistry Laboratory, Department of Laboratory Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands., Berven FS; Proteomics Unit at the University of Bergen, Department of Biomedicine, University of Bergen, Bergen, Norway., Visser PJ; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.; Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
Publikováno v: Nature aging [Nat Aging] 2024 Jan; Vol. 4 (1), pp. 33-47. Date of Electronic Publication: 2024 Jan 09.
Zobrazit plný text záznamu
10
Akademický článek
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity.
Autor: Bartaula-Brevik S; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Leitch C; Department of Clinical Science, Centre for Pharmacy, University of Bergen, 5015 Bergen, Norway., Hernandez-Valladares M; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.; Department of Physical Chemistry, University of Granada, Avenida de la Fuente Nueva S/N, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain., Aasebø E; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Berven FS; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Selheim F; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Brenner AK; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Rye KP; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Hagen M; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Reikvam H; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway., McCormack E; Department of Clinical Science, Centre for Pharmacy, University of Bergen, 5015 Bergen, Norway., Bruserud Ø; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway., Tvedt THA; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Aug 25; Vol. 12 (17). Date of Electronic Publication: 2023 Aug 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje